prostate cancer prostatic adenocarcinoma
Conditions
Interventions
GP-based follow-up and aftercare for prostatecancer survivors
Sponsors
Nederlands Kanker Instituut
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Men diagnosed with invasive prostate cancer; - Stage cT1a - cT3; pNx - pN1; R0-1 having completed primary treatment (prostatectomy or radiotherapy); - Radiotherapy with or without androgen deprivation therapy (ADT) for localized prostate cancer - No evidence of recurrence (PSA
Exclusion criteria
Exclusion criteria: - Primary treatment (prostatectomy, radiotherapy) completed longer than 6 months previously; - Patients under active surveillance; - Under investigation for possible recurrence (patients become eligible if recurrence is ruled out); - Does not have a community-based GP to provide care; - Unable to comply with study protocol including completion of questionnaires; - Actively followed by a cancer specialist for another primary cancer; - (Previously) enrolled in a study requiring ongoing follow-up by a cancer specialist; - Serious (treatment related) toxicity that requires treatment; - Patients that cannot sign informed consent or are unable to understand Dutch.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is the effect of GP-based versus specialist-based follow-up care on adherence to the prostate cancer surveillance guideline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include the time from a biochemical recurrence (BCR) to prostate cancer retreatment decision-making in an interdisciplinary setting, management of treatment-related side effects and comorbidities, health promotion recommendations, prostate-cancer related anxiety and quality of life, continuity of care, and cost-effectiveness. | — |
Countries
Netherlands
Outcome results
None listed